Literature DB >> 15112344

Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis.

Shi-Min Luo1, Li-Jian Liang, Jia-Ming Lai.   

Abstract

AIM: To explore the effects of recombinant human growth hormone (rhGH) on the remnant liver after hepatectomy in hepatocellular carcinoma with liver cirrhosis.
METHODS: Twenty-four patients with hepatocellular carcinoma who underwent hepatectomy were randomly divided into 2 groups: parenteral nutrition (PN) group (n=12) and rhGH+PN group (n=12). Liver function, blood glucose, AFP, serum prealbumin and transferrin were detected before operation, at post-operative d 1 and d 6. Albumin (ALB) mRNA in liver biopsy specimens was detected by RT-PCR at post-operative d 6. Liver Ki67 immunohistochemical staining was studied.
RESULTS: On post-operative d 6, compared with PN group, the levels of blood glucose, serum prealbumin, transferrin, the expression of hepatic ALB mRNA and liver Ki67 labeling index were higher in rhGH+PN group.
CONCLUSION: rhGH can improve protein synthesis and liver regeneration after hepatectomy in hepatocellular carcinoma with liver cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112344      PMCID: PMC4622768          DOI: 10.3748/wjg.v10.i9.1292

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  Intensify standardized therapy for esophageal and stomach cancer in tumor hospitals.

Authors:  S J Wang; D G Wen; J Zhang; X Man; H Liu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  The metabolic role of branched-chain amino acids.

Authors:  Herbert R Freund; Menachem Hanani
Journal:  Nutrition       Date:  2002-03       Impact factor: 4.008

3.  Hepatic function immediately after hepatectomy as a significant risk factor for early recurrence in hepatocellular carcinoma.

Authors:  K Hanazaki; M Wakabayashi; H Sodeyama; S Kajikawa; J Amano
Journal:  Hepatogastroenterology       Date:  1999 Nov-Dec

Review 4.  Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.

Authors:  Hui-Chuan Sun; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Depression of liver protein synthesis during surgery is prevented by growth hormone.

Authors:  H Barle; P Essén; B Nyberg; H Olivecrona; M Tally; M A McNurlan; J Wernerman; P J Garlick
Journal:  Am J Physiol       Date:  1999-04

Review 6.  Irreversible intestinal failure, nutrition support, and small bowel transplantation.

Authors:  P Dionigi; M Alessiani; A Ferrazi
Journal:  Nutrition       Date:  2001-09       Impact factor: 4.008

Review 7.  Branched chain amino acids in heptatic encephalopathy.

Authors:  J Howard James
Journal:  Am J Surg       Date:  2002-04       Impact factor: 2.565

8.  In situ hybridization of albumin mRNA in normal liver and liver tumors: identification of hepatocellular origin.

Authors:  K Yamaguchi; M A Nalesnik; B I Carr
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1993

9.  The inefficiency of total parenteral nutrition to stimulate protein synthesis in moderately malnourished patients.

Authors:  I Warnold; E Edén; K Lundholm
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

10.  Impact of perioperative treatment of recombinant human growth hormone on cell immune function and intestinal barrier function: randomized, double-blind, controlled trial.

Authors:  Wei Liu; Zhu Jiang; Xiu Wang; Hong Shu; Wei Cui; Douglas W Wilmore
Journal:  World J Surg       Date:  2003-04       Impact factor: 3.352

View more
  4 in total

Review 1.  Systematic review of pathophysiological changes following hepatic resection.

Authors:  Joey Siu; John McCall; Saxon Connor
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

Review 2.  Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.

Authors:  Mark Pines
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 3.  Research Progress and Treatment Status of Liver Cirrhosis with Hypoproteinemia.

Authors:  Jianxia Wen; Xing Chen; Shizhang Wei; Xiao Ma; Yanling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-24       Impact factor: 2.629

4.  A proteomic approach identified growth hormone-dependent nutrition markers in children with idiopathic short stature.

Authors:  Gunnel Hellgren; Björn Andersson; Andreas Fm Nierop; Jovanna Dahlgren; Ze'ev Hochberg; Kerstin Albertsson-Wikland
Journal:  Proteome Sci       Date:  2008-12-11       Impact factor: 2.480

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.